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In the kidney, a high salt intake favors oxidative stress and hypoxia and causes the development of fibrosis. Both atrial natriuretic
peptide (ANP) and hypoxia inducible factor (HIF-1𝛼) exert cytoprotective effects. We tested the hypothesis that renal expression
of ANP and HIF-1𝛼 is involved in a mechanism responding to the oxidative stress produced in the kidneys of rats chronically fed a
high sodium diet. Sprague-Dawley rats were fed with a normal salt (0.4%NaCl) (NS) or a high salt (8%NaCl) (HS) diet for 3 weeks,
with or without the administration of tempol (T), an inhibitor of oxidative stress, in the drinking water. We measured the mean
arterial pressure (MAP), glomerular filtration rate (GFR), and urinary sodium excretion (UVNa). We evaluated the expression of
ANP, HIF-1𝛼, and transforming growth factor (TGF-𝛽1) in renal tissues by western blot and immunohistochemistry. The animals
fed a high salt diet showed increased MAP and UVNa levels and enhanced renal immunostaining of ANP, HIF-1𝛼, and TGF-𝛽1.
The administration of tempol together with the sodium overload increased the natriuresis further and prevented the elevation of
blood pressure and the increased expression of ANP, TGF-𝛽1, and HIF-1𝛼 compared to their control. These findings suggest that
HIF-1𝛼 and ANP, synthesized by the kidney, are involved in an adaptive mechanism in response to a sodium overload to prevent
or attenuate the deleterious effects of the oxidative stress and the hypoxia on the development of fibrosis.
1. Introduction
Reactive oxygen species (ROS) have been demonstrated
to play an important pathophysiological role in the kid-
ney [1–4]. ROS can activate the mitochondrial uncoupling
protein 2 (UCP-2), leading to inefficient renal O
2
usage
and contributing to renal hypoxia [5]. Changes in cellular
oxygen concentrations induce tightly regulated response
pathways that attempt to restore oxygen supply to cells
and modulate cell function in hypoxic conditions. Most of
these responses occur through the induction of the tran-
scription factor hypoxia inducible factor-1 (HIF-1) which
coordinates the expression of diverse adaptive genes against
the hypoxic injury [6, 7]. HIF-1 transcriptionally upregulates
the expression of metabolic proteins (GLUT-1), adhesion
proteins (integrins), soluble growth factors (TGF-𝛽 and
VEGF), and extracellularmatrix components (type I collagen
and fibronectin), which enhance the repair process. For these
reasons, HIF-1 is viewed as a positive regulator of organ repair
and tissue fibrosis [8, 9].
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In the kidney, a predominant enzyme involved in
oxidative stress development is NADPH-oxidase, which
is upregulated by increased sodium tubular transport,
luminal flow, or cytokines release [10, 11]. In turn, the
superoxide anion increases tubular NaCl transport, fur-
ther enhancing oxidative stress [12]. It is well known that
a high salt intake increases the oxidative stress in the
kidneys of normal and salt-sensitive rats [1–4]. In this
regard, we have reported that a high salt diet in Sprague-
Dawley rats is able to increase the oxidative stress. We
also showed that the administration of tempol (4-hydroxy-
2,2,6,6-tetramethylpiperidine-N-oxyl), which is a permeate
superoxide dismutase mimetic commonly used to inhibit the
oxidative stress, prevented those changes and produced a
potent natriuretic and diuretic effect. Thus, we concluded
that the increase of the oxidative stress induced by sodium
overload could account for antinatriuresis [1]. It has also
been described that, in models of experimental salt-sensitive
hypertension, tempol improved the renal hemodynamic
response and electrolyte excretory function, while abolish-
ing salt-sensitive hypertension and renal oxidative stress
[13].
A growing number of mammalian genes have been
identified to play a key role in the cellular adaptive response
to counter-regulate the renal hypoxia and the consequent
process of fibrosis, among which is atrial natriuretic peptide
(ANP). ANP is a member of a natriuretic peptide family
which, besides its role in the regulation of volume homeosta-
sis, has been noted to exert protective effects in several cell
types in response to oxidative stress [14] and fibrosis [15] and
on the adaptation to hypoxia [16].
Based on these data, we hypothesized that endogenous
renal ANP andHIF-1𝛼 could constitute endogenous adaptive
mechanisms in response to the oxidative stress produced in
the kidney of rats chronically fed with a high sodium diet.
Therefore, in the current study we determined the effect
of a high-salt diet on the regulation of renal expression
of HIF-1𝛼, ANP, and TGF-𝛽1 in Sprague-Dawley rats. In
addition, we evaluated whether tempol administration, by
inhibiting oxidative stress, prevents the increase of these
molecules. Understanding these endogenous mechanisms
can lead to finding a better therapeutic approach in salt-
sensitive hypertension.
2. Methods
2.1. Animal Protocol and ExperimentalMeasurements. Exper-
iments were conducted in accordance with the care and use
of research animals of international guiding principles and
local regulations concerning the care and use of laboratory
animals for biomedical research (ANMAT, 6344/96; Institute
of Laboratory Animal Resources, 1996) (14), as well as the
“International Ethical Guiding Principles for Biomedical
Research onAnimals” established by theCIOMS (Council for
International Organizations of Medical Sciences) (15). These
protocols were approved by Universidad de Buenos Aires
(UBACYT B113) and the National Scientific and Technical
Research Council (CONICET, PIP 1337/09).
Male Sprague Dawley rats, 5-6 weeks old (180–200 g body
weight), were used in the experiments. The animals were
housed in steel cages in a controlled temperature animal
room at 23 ± 2∘C, exposed to a daily 12-hour light-dark
cycle (light on from 07:00 a.m. to 07:00 p.m.), fed the diets
described below for three weeks, andwere given free access to
tap water. The experiments were performed in rats randomly
divided into four groups (𝑛 = 6 for each group): (a) NS
(control): fed a normal salt diet (0.4 g% NaCl); (b) HS:
fed a high salt diet (8% g NaCl); (c) NS-T: fed a normal
salt diet (0.4 g% NaCl) plus 1mM tempol (Sigma-Aldrich
Inc, St. Louis, Missouri, USA), administered in the drinking
water; (d) HS-T: fed a high salt diet (8% g NaCl) plus 1mM
tempol administered in the drinking water. After 3 weeks,
the rats were anaesthetized intraperitoneally with urethane
(1.2 g⋅kg−1) and a PE-90 tube (3 cm long) was inserted into
the trachea to maintain an open airway. The left femoral vein
was catheterized with a Silastic cannula (0.12mm i.d.) for
continuous infusion.The right carotid arterywas catheterized
with a T4 tube for blood sampling and for continuous mean
arterial pressure recording (MAP) by means of a Statham
GOULD P23ID transducer coupled to a Grass Polygraph
79D during all the procedures. The bladder was cannulated
for urine collection using a PE-75 cannula. A femoral vein
infusion with isotonic saline solution (ISS, 0.15M NaCl)
was performed at a rate of 0.04mL⋅min−1 (Syringe Infusion
Pump, Sage, Orion) for 60 minutes to allow for a steady
diuresis and to permit urine collection in all groups.Then, ISS
infusion continued for another 60min at the same rate during
the experimental period. From each animal, a blood sample
was collected at 30 minutes and a urine sample was collected
from 0 to 60 minutes for sodium, potassium, and creatinine
measurements. At the end of the experimental period, other
blood samples were obtained from the abdominal cava vein,
immediately placed into plastic tubes containing 15% EDTA,
and kept on ice for ANP dosage. The kidney was rapidly
excised, decapsulated, longitudinally cut, and harvested for
immunohistochemical studies.
2.2. ANP Radioimmunoassay. The plasma ANP extraction
procedure was followed as described by Cavallero et al.
[17]. The radioimmunoassay (RIA) was performed using
an ANP-rat RIA commercial kit (Phoenix Pharmaceuticals,
Burlingame, CA) [18].
2.3. Urine and Blood Measurements. Urinary and plasma
sodium and creatinine were measured by standard methods
using an autoanalyzer. Creatinine clearance was assessed
in order to evaluate the glomerular filtration rate (GFR).
GFR and sodium fractional excretion (FENa) were calculated
according to a standard formula. Urinary flow (UV) is
expressed as 𝜇L⋅min−1, plasmatic sodium (PLNa) concen-
tration as mEq⋅L−1, sodium urinary excretion (UVNa) as
𝜇mol⋅min−1, GFR as mL⋅min−1, and FENa as percentage.
2.4. Kidney Processing for Histological Examination. Renal
tissues were fixed in phosphate-buffered 10% formaldehyde
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(pH 7.20) and embedded in paraffin. For immunohisto-
chemistry, sections were deparaffinated and rehydrated, and
endogenous peroxidase activity was blocked by treatment
with 0.5% H
2
O
2
in methanol for 20 minutes. Local ANP,
HIF-1𝛼, and TGF-𝛽1 were detected using the following
specific antibodies: rabbit anti-ANP (Phoenix Pharmaceuti-
cal; dilution 1 : 500), rabbit anti-HIF-1𝛼 (Novus Biologicals,
Inc., Littleton, CO; dilution 1 : 1000), and rabbit anti-TGF-
𝛽1 (Santa Cruz Biotechnology; dilution 1 : 200). Immunos-
taining was performed with a commercial modified avidin-
biotin-peroxidase complex technique (Vectastain ABC kit,
Universal Elite, Vector Laboratories, CA) and with coun-
terstaining with haematoxylin. Histological sections were
observed in a Nikon E400 light microscope (Nikon Instru-
ment Group, Melville, New York, USA). All measurements
were carried out using image analysis software (Image-Pro
Plus ver. 4.5 for Windows, Media Cybernetics, LP. Silver
Spring,MD,USA). Immunoreactivities for ANP, HIF-1𝛼, and
TGF-𝛽1 are expressed as percentage of positive stained area
± standard error of the mean (SEM) in proximal convoluted
tubules (PT), distal tubules (DT), thick ascending limb of the
loop of Henle (THAL), cortical collecting ducts (CCD), and
medullary collecting ducts (MCD). Tissue samples of all the
animals were evaluated in a blinded fashion and separately by
two researchers regarding knowledge of treatments.
2.4.1. Preparation of RenalHomogenates forWestern Blot. The
right kidney from all groups was extracted, dissected, and
separated. Tissue samples were homogenized on ice with
a Tissue Tearor (Biospec Products Inc.) in a buffer mix-
ture (50mmol⋅L−1 Tris, 0.1mmol⋅L−1 EDTA, 0.1mmol⋅L−1
EGTA, 1% Triton, 1mmol⋅L−1 PMSF, 1 𝜇mol⋅L−1 pepstatin,
2 𝜇mol⋅L−1 leupeptin, and 1x protease inhibitor cocktail
(Roche Diagnostics). Protein concentration in the Triton-
soluble supernatant was determined by the Lowry technique.
2.4.2. Western Blot Analysis for HIF-1𝛼 and ANP. Pooled
samples of renal tissue from five animals of each group and
containing similar amounts of protein (150𝜇g protein/lane)
were separated by electrophoresis in 10% SDS polyacry-
lamide gels (Bio-Rad) and then transferred to a nitrocellulose
membrane (Bio-Rad) and incubated with mouse polyclonal
anti-ANP (Santa Cruz Biotechnology, Inc. 1 : 800 dilution)
or rabbit monoclonal-anti-HIF-1𝛼 (Abcam; 1 : 1000 dilution).
For ANP, a secondary immune reaction followed with a
goat anti-rabbit IgG (H + L) conjugated with horseradish
peroxidase (dilution of 1 : 10000). For HIF-1𝛼 a secondary
immunereaction followed with a biotinylated anti-rabbit
(dilution of 1 : 1000) and a 3rd antibody conjugated with
horseradish peroxidase (dilution of 1 : 1000). The samples
were revealed by chemiluminescence using ECL reagent
(Amersham Pharmacia Biotech) for 2–4min. The density
of the respective bands was quantified by densitometric
scanning of Western blots using a Hewlett-Packard scanner
andTotallab analyzer software (BiodynamicsCorp.). To avoid
inaccuracies in protein loading, beta-tubulin was measured
as internal standard (anti-beta tubulin, Ab 6046, rabbit
polyclonal antibody) for each blot and protein levels were
calculated and expressed as the ratio between the optical
densities of the bands corresponding to ANP or HIF-1𝛼 and
𝛽-tubulin.
2.5. Statistical Analysis. Results from urine and blood mea-
surements andMAP are expressed as mean ± SEM. Gaussian
distribution was evaluated by the Kolmogorov and Smirnov
method and the comparison among groups was carried out
using ANOVA followed by the Bonferroni test. 𝑃 values <
0.05 were considered significant.
3. Results
3.1. Body Weight and Mean Arterial Pressure. There were no
significant differences in body weight between control and
experimental groups (grams; NS: 330 ± 9; HS: 320 ± 6; NS-
T: 314 ± 13; HS-T: 320 ± 7).
TheMAPwas increased in the HS fed group compared to
the NS-fed group (mmHg; NS: 94 ± 3 versus HS: 107 ± 3∗).
Tempol administration did not modify MAP levels in NS
animals but normalized MAP in the HS-T group, reaching
MAP levels very similar to those observed inNS rats (mmHg;
NS-T: 97 ± 2 versus HS-T: 95 ± 3†) ∗𝑃 < 0.05 versus
respective NS group, †𝑃 < 0.05 versus respective group
without tempol.
3.2. Plasma Sodium and Urinary Sodium Excretion (Table 1).
High salt diet and tempol administration did not alter plasma
sodium in any experimental group.
The administration of a high salt diet did not alter
the GFR, which was increased by tempol in HS-T group
with respect to the HS group. Tempol administration also
increased GFR in the NS-T group as compared with the NS
group.
The administration of a high salt diet led to a greater
UVNa, which was further increased in HS-T group with
respect to the NS-T and HS groups. Moreover, tempol
increased UVNa in NS fed rats.
The administration of a high salt diet raised FENa in HS
group with respect to the NS group. Tempol administration
increased the FENa further in the HS-T group as compared
with NS-T and to the HS group. FENa was not altered in the
NS-T group.
3.3. Plasmatic ANP. Plasma ANP concentration (pg⋅mL−1)
did not differ significantly between the NS (325.75 ± 66.69)
and HS (260.00 ± 7.38) groups, as measured by RIA.
3.4. Intrarenal ANP Expression. Figure 1 shows quantified
levels of ANP immunoexpression in renal tissues. Repre-
sentative images of ANP positive staining are shown in
Figure 2(a) renal cortex and Figure 2(b) renal medulla. The
analysis of renal sections obtained from the HS group
revealed increased positive staining for ANP in glomeruli,
THAL, and CCD with respect to the NS group. Tempol
prevented the elevation of ANP staining in HS-T group in
4 BioMed Research International
ANP staining (%)
0
10
20
30
MCD
0
4
8
12 CCD
Glomeruli
0
4
8
12
16
20
NS HS NS-T HS-T
NS HS NS-T HS-T
NS HS NS-T HS-T
∗
∗
#
#
#
#
0
2
4 THAL
NS HS NS-T HS-T
∗
#
PT
0
4
8
12
16
20
NS HS NS-T HS-T
# #
Figure 1: Quantitative representation of positive intrarenal atrial natriuretic peptide (ANP) immunostaining/𝜇m2. Values are expressed as
percentage ± SEM, 𝑛 = 5-6, ∗𝑃 < 0.05 versus respective NS control; #𝑃 < 0.05 versus respective control without tempol. NS: normal salt diet
group, HS: high salt diet group, NS-T: normal salt diet plus tempol group, HS-T: high salt diet plus tempol group. PT: proximal tubule, CCD:
cortical collecting duct, THAL: thick ascending limb of the loop of Henle, and MCD: medullary collecting duct.
glomeruli, THAL, and CCD and decreased ANP staining in
PT and MCD of both NS-T and HS-T groups.
Figure 3(a) shows quantified protein expression of ANP
in renal tissue byWestern blot analysis. The analysis revealed
increased positive staining of HS group for ANP. Tempol
decreased the expression of both NS-T and HS-T groups
compared to their respective control without tempol.
3.5. Intrarenal HIF-1𝛼 Expression. Figure 4 shows quantified
levels of HIF-1𝛼 immunoexpression in renal tissues. Rep-
resentative images of HIF-1𝛼 positive staining are shown
in Figure 5(a) renal cortex and Figure 5(b) renal medulla.
Immunostaining analysis of renal sections obtained from
HS group revealed that HIF-1𝛼 staining was increased in all
examined tubular segments (PT,DT,CCD,THAL, andMCD)
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Table 1: Renal function parameters.
NS HS NS-T HS-T
PLNa (mEq⋅L
−1) 142 ± 1 145 ± 2 143 ± 1 143 ± 2
GFR (mL⋅min−1) 1.51 ± 0.1 1.48 ± 0.1 3.4 ± 0.8† 3.1 ± 0.7†
UVNa (𝜇mol⋅min
−1
⋅kg−1) 0.23 ± 0.1 3.50 ± 0.64∗ 2.00 ± 0.92† 13.0 ± 1.5∗†
FENa (%) 0.04 ± 0.02 0.53 ± 0.08
∗
0.12 ± 0.06 1.20 ± 0.20
∗†
All values are mean ± SEM, 𝑛 = 5-6, ∗𝑃 < 0.05 versus respective NS group, †𝑃 < 0.05 versus respective group without tempol. NS: normal salt diet group, HS:
high salt diet group, NS-T: normal salt diet plus tempol group, HS-T: high salt diet plus tempol group, PLNa: plasmatic sodium concentration, GFR: glomerular
filtration rate, UVNa: urinary sodium excretion, and FENa: fractional sodium excretion.
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Figure 2: (a) Representative images of positive staining of atrial natriuretic peptide (ANP) in renal cortex. (b) Representative images of
positive staining of ANP in renal medulla. Original magnification 400x. NS: normal salt diet group, HS: high salt diet group, NS-T: normal
salt diet plus tempol group, HS-T: high salt diet plus tempol group. G: glomerulus, CCD: cortical collecting duct, MCD: medullary collecting
duct.
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Figure 3: RepresentativeWestern blot analysis in renal tissue of ANP (a) and HIF-1𝛼 (b). NS: normal salt diet group, HS: high salt diet group,
NS-T: normal salt diet plus tempol group, and HS-T: high salt diet plus tempol group. Histograms illustrate the values of protein expression
of ANP and HIF-1𝛼 for every group. Each blot was normalized to the expression of 𝛽-tubulin from the same gel. Data are mean ± SEM,
expressed as arbitrary units. 𝑛 = 5-6. ∗𝑃 < 0.05 versus NS group; #𝑃 < 0.05 versus respective group without tempol.
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Figure 4: Quantitative representation of positive intrarenal hypoxia inducible factor-1 (HIF-1𝛼) immunostaining/𝜇m2. Values are expressed
as percentage ± SEM. 𝑛 = 5-6. ∗𝑃 < 0.05 versus respective NS control; #𝑃 < 0.05 versus respective control without tempol. NS: normal salt
diet group, HS: high salt diet group, NS-T: normal salt diet plus tempol group, HS-T: high salt diet plus tempol group. PT: proximal tubule,
DT: distal tubule, CCD: cortical collecting duct, THAL: thick ascending limb of the loop of Henle, and MCD: medullary collecting duct.
with respect to the NS group. The administration of tempol
did not alter HIF-1𝛼 staining in the NS-T group, except in
THAL where it was augmented. Whereas in HS-T group,
HIF-1𝛼 staining decreased in all tubular segments except in
THAL compared with HS group.
The quantified protein expression of HIF-1𝛼 in renal
tissue byWestern blot analysis can be observed in Figure 3(b).
The analysis revealed increased positive staining of HS group
for HIF-1𝛼. Tempol decreased the expression in HS-T groups
compared to its control without tempol.
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Figure 5: (a) Representative images of positive staining of hypoxia inducible factor-1 (HIF-1𝛼) in renal cortex. (b) Representative images of
positive staining of HIF-1𝛼 in renal medulla. Original magnification 400x. NS: normal salt diet group, HS: high salt diet group, NS-T: normal
salt diet plus tempol group, HS-T: high salt diet plus tempol group. PT: proximal tubule, DT: distal tubule, and MCD: medullary collecting
duct.
3.6. Intrarenal TGF-𝛽1 Expression. Figure 6 shows quantified
levels of TGF-𝛽1 immunoexpression in renal tissues. Repre-
sentative images of TGF-𝛽1 positive staining are shown in
Figure 7 in (a) renal cortex and (b) renal medulla. Immunos-
taining analysis of renal sections revealed increased positive
staining for TGF-𝛽1 in glomeruli, THAL, CCD, and theMCD
in HS group, with respect to the NS group. Tempol did not
show additional effects in the NS-T group as compared with
its control and prevented the increase of TGF-𝛽1 staining in
HS-T group.
4. Discussion
Our results showed that a high salt diet in normal rats resulted
in a greater ANP expression in glomeruli, THAL and CCD,
where the profibrotic marker TGF-𝛽1 was also increased.
In addition, enhanced HIF-1𝛼 expression was observed not
only in the renal medulla as it has been previously described
[19], but also in renal cortex. We found that tempol admin-
istration, a superoxide dismutase mimetic, favored urinary
sodium excretion, prevented the increase of ANP and TGF-
𝛽1 expression, and normalized HIF-1𝛼 expression, the latter
except in THAL. Western blot analysis confirmed our data,
showing increased positive staining of HS group for ANP
and HIF-1𝛽 and decreased the expression of tempol groups
compared to their respective controls. These results suggest
that increased ANP and HIF-1𝛼 expression in renal cortex
and medulla could be involved in an adaptive response to the
oxidative stress resulting from a high salt diet.
As we have previously reported, a chronic salt overload
(8% NaCl diet during 3 weeks) does not alter body weight
or plasma sodium but causes higher MAP levels as well
as urinary sodium excretion [1]. Even though the animals
used in this study have their blood pressure taken under
anesthesia, we have recently reported the same effect of a
high salt diet on theMAP in conscious animals [20], allowing
us to conclude that the anesthesia does not affect the blood
pressure when the different diet groups are compared. On the
other hand, the administration of tempol normalized MAP
levels observed in the HS group, and it also increased further
urinary sodium excretion. These results are in agreement
with previous studies, where treatmentwith tempol improved
renal hemodynamic and electrolyte excretory function in
salt-sensitive hypertension models [1, 21]. The effects of
tempol, promoting natriuresis and preventing endogenous
increase of ANP, could suggest that, by inhibiting oxidative
stress, tubular sodium transport decreases and thus prevents
the endogenous ANP expression as natriuretic hormone.
However, we observed a clear raise in ANP expression
also in glomeruli from rats fed a high salt diet, in which
sodium transport does not occur. Therefore, in addition to
a natriuretic effect, endogenous ANP could be exerting other
effects in glomeruli and tubules. Furthermore, the increase
of renal ANP levels coincided with TGF-𝛽1 over-expression
in glomeruli, THAL and CCD. In this regard, it is known
that TGF-𝛽1 upregulates the transcription of the serum and
glucocorticoid-dependent kinase hSGK1, involved in the reg-
ulation of two important factors for cell volume regulation,
that is, the renal epithelial Na+ channel ENaC and the thick
ascending limb Na+, K+, and 2Cl− cotransporter NKCC
[22]. The increase of cell volume stimulates protein synthesis
and inhibits protein degradation, contributing to enhancing
the net formation and deposition of matrix proteins. In
addition, TGF-𝛽1 transduces intracellular signals through
type 1 (TGF-𝛽R1) and type 2 (TGF-𝛽R2) receptors, via the
nuclear translocation of Smad3 proteins, thus contributing
to a fibrotic response [23]. It has been demonstrated that
the activation of ANP/cGMP/PKG signaling phosphorylates
Smad3 and disrupts TGF-𝛽1-induced nuclear translocation
of pSmad3 and later downstream events, including myofi-
broblast transformation and the proliferation and expression
of extracellular matrix molecules [24, 25]. Moreover, we
have previously demonstrated that an increase in TGF-
𝛽1 expression produced by an acute saline overload was
prevented and reversed by the administration of low and
nonhypotensive doses of ANP [26]. Taking this into account,
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Figure 6:Quantitative representation of positive intrarenal transforming growth factor (TGF-𝛽1) immunostaining/𝜇m2. Values are expressed
as percentage ± SEM, 𝑛 = 5-6. ∗𝑃 < 0.05 versus respective control NS; #𝑃 < 0.05 versus respective control without tempol. NS: normal salt
diet group, HS: high salt diet group, NS-T: normal salt diet plus tempol group, HS-T: high salt diet plus tempol group, PT: proximal tubule,
CCD: cortical collecting duct, THAL: thick ascending limb of the loop of Henle, and MCD: medullary collecting duct.
the present results suggest that the raise of ANP expression in
rats fed a high salt diet could constitute a counter-regulatory
mechanism against antinatriuretic and/or profibrotic TGF-𝛽1
actions.
Meanwhile, the plasmatic concentration of ANP was not
affected by dietary salt, suggesting that these animals did not
change cardiac ANP secretion [17]. Several reports provide
evidence that plasmatic ANP increases after a chronic salt
loading given by drinking 1–18% NaCl solutions [27, 28]
or by a rat chow with high salt content [29]. However, the
literature also shows conflicting results reporting that ANP
mRNA expression and circulating levels of ANP remained
unaltered after the ingestion of high sodium diets [30]. The
present results show that renal ANP expression levels are
independent of circulating ANP levels and are subjected to
a different regulation. These findings are in accordance with
Sun et al. who have previously demonstrated that a dietary
salt supplementation may selectively increase ANP levels in
the kidney by downregulating its clearance receptor (NPR-C)
[31].
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Figure 7: (a) Representative images of positive staining of TGF-𝛽1 in renal cortex. (b) Representative images of positive staining of TGF-𝛽1
in renal medulla. Original magnification 400x. NS: normal salt diet group, HS: high salt diet group, NS-T: normal salt diet plus tempol group,
HS-T: high salt diet plus tempol group, G: glomerulus, and MCD: medullary collecting duct.
Our study also shows that a high salt intake increased
HIF-1𝛼 expressionnot only in the renalmedulla, as it has been
described before [18], but also in renal cortex. Considering
that a high salt intake increases oxidative stress, renal tubular
transport, and hypoxia, it may constitute one of the possible
factors involved in the upregulation of HIF-1𝛼 expression in
renal tissues [6, 32]. Additionally, it has been reported that a
high salt intake inhibits PHD-2 expression, the predominant
isoform in renal medulla of prolyl-hydroxylase enzyme,
which promotes the degradation of HIF-1𝛼, increasing its
expression level [33]. In this way, recent studies have shown
that HIF-1𝛼 may regulate the encoding genes of some
enzymes in the THAL, as those of nitric oxide synthase
(NOS), cyclooxygenase-2 (COX-2), and hemeoxygenase-1
(HO-1), which are highly expressed in renal medulla [34,
35]. However, the tempol administration, which prevents
oxidative stress and enhanced urinary sodium excretion,
normalized HIF-1𝛼 expression in the HS group, except in
THAL from both groups fed a normal or a high salt diet.
These data suggest that tempol could prevent the hypoxia
produced by the oxidative stress as it has been described
[5, 20], but not the hypoxia produced by greater sodium
transport in THAL, where the enhancement of sodium
reabsorption in this tubular segment may be compensat-
ing the inhibition of sodium transport in PT, elicited by
tempol.
In summary, the present findings suggest that HIF-1𝛼
and ANP could represent a main adaptive mechanism in
normal rats, in response to a salt overload, counter-regulating
the hypoxia and fibrosis produced by oxidative stress, and
playing a crucial role in the maintenance of sodium balance.
The administration of tempol, as a scavenger of superoxide
anion, prevents overexpression of 𝛼 and ANP.The disruption
of this salt adaptive pathway in salt-sensitive rats could be
the cause of sodium retention, oxidative stress, inflammation,
and fibrosis in these animals. The pharmacological poten-
tiation of endogenous ANP may be a therapeutic approach
for the management of oxidative stress in salt-sensitive
hypertension.
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